FT
FHTX icon

Fiduciary Trust’s Foghorn Therapeutics FHTX Stock Holding History

Fiduciary Trust’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52K Hold
10,879
– – ﹤0.01% 863
2025
Q4 		$58.7K Hold
10,879
– – ﹤0.01% 855
2025
Q3 		$53.2K Hold
10,879
– – ﹤0.01% 844
2025
Q2 		$51.1K Hold
10,879
– – ﹤0.01% 823
2025
Q1 		$39.7K Hold
10,879
– – ﹤0.01% 813
2024
Q4 		$51.3K Hold
10,879
– – ﹤0.01% 684
2024
Q3 		$101K Hold
10,879
– – ﹤0.01% 644
2024
Q2 		$62.6K Hold
10,879
– – ﹤0.01% 621
2024
Q1 		$73K Hold
10,879
– – ﹤0.01% 636
2023
Q4 		$70.2K Hold
10,879
– – ﹤0.01% 616
2023
Q3 		$54.4K Hold
10,879
– – ﹤0.01% 604
2023
Q2 		$76.6K Hold
10,879
– – ﹤0.01% 617
2023
Q1 		$67.5K Hold
10,879
– – ﹤0.01% 606
2022
Q4 		$69.4K Hold
10,879
– – ﹤0.01% 615
2022
Q3 		$93K Hold
10,879
– – ﹤0.01% 596
2022
Q2 		$148K Hold
10,879
– – ﹤0.01% 607
2022
Q1 		$166K Hold
10,879
– – ﹤0.01% 645
2021
Q4 		$249K Hold
10,879
– – ﹤0.01% 598
2021
Q3 		$152K Hold
10,879
– – ﹤0.01% 635
2021
Q2 		$116K Hold
10,879
– – ﹤0.01% 628
2021
Q1 		$143K Hold
10,879
– – ﹤0.01% 595
2020
Q4 		$221K Buy
+10,879
New +$208K ﹤0.01% 544

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fiduciary Trust's FHTX Position: Q1 2026 in Review

Fiduciary Trust held its Foghorn Therapeutics (FHTX) position steady in Q1 2026 at 10,879 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

Fiduciary Trust first reported a position in FHTX in Q4 2020 and has held it in 22 quarters since. The position peaked at $249K in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Fiduciary Trust held 10,879 shares of Foghorn Therapeutics worth $52K as of Q1 2026.
  • Fiduciary Trust left its Foghorn Therapeutics share count unchanged in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Fiduciary Trust's portfolio in Q1 2026, its #863 holding.
  • Fiduciary Trust first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Fiduciary Trust's Foghorn Therapeutics position peaked at $249K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.